Suppliers and packagers for cordran

cordran

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Ina Pharms	CORDRAN	flurandrenolide	OINTMENT;TOPICAL	012806	NDA	INA Pharmaceutics, Inc	74157-130-07	1 TUBE in 1 CARTON (74157-130-07) / 120 g in 1 TUBE	2025-07-07
Ina Pharms	CORDRAN	flurandrenolide	OINTMENT;TOPICAL	012806	NDA	INA Pharmaceutics, Inc	74157-180-60	1 TUBE in 1 CARTON (74157-180-60) / 60 g in 1 TUBE	2025-07-07
Almirall	CORDRAN	flurandrenolide	TAPE;TOPICAL	016455	NDA	Almirall, LLC	16110-587-24	1 BOTTLE in 1 CARTON (16110-587-24) / 450 cm2 in 1 BOTTLE	2018-09-24
Almirall	CORDRAN	flurandrenolide	TAPE;TOPICAL	016455	NDA	Almirall, LLC	16110-587-80	1 BOTTLE in 1 CARTON (16110-587-80) / 1500 cm2 in 1 BOTTLE	2018-09-24

Suppliers for the Pharmaceutical Drug: CORDRAN

Last updated: August 9, 2025

Introduction

Cordran, a dermatological medication primarily used for treating inflammatory skin conditions, is a corticosteroid topical formulation. Its active ingredient, flurandrenolide, is a potent corticosteroid often prescribed for conditions like eczema, psoriasis, and dermatitis. As with many specialty pharmaceuticals, identifying reliable suppliers is critical for healthcare providers, pharmacies, and distributors to ensure consistent drug availability, quality, and compliance with regulatory standards. This analysis explores the key suppliers of Cordran, examining their manufacturing capabilities, regulatory status, and market reach to provide a comprehensive understanding for stakeholders.

---

Overview of Cordran and Its Market Position

Cordran, branded by various pharmaceutical manufacturers, is recognized for its unique semi-fluid, tape-like, or ointment formulations of flurandrenolide. Since its approval by regulatory agencies such as the U.S. Food and Drug Administration (FDA), it has established a niche within dermatological therapeutics. Market demand for corticosteroid topicals like Cordran remains steady due to the prevalence of skin inflammatory conditions.

The manufacturing landscape involves both original brand companies and generic manufacturers. While the original formulations often come from patent-holding pharmaceutical giants, generic versions expand accessibility and affordability, influencing supplier dynamics.

---

Major Suppliers of Cordran

1. Novartis

Overview: Novartis historically held the patent and marketed Cordran in various formulations. Although they primarily distribute branded corticosteroid products globally, their dermatology portfolio includes products with similar formulations.

Supply Chain Role: Novartis functions as a primary supplier in markets where its formulations of flurandrenolide are approved. Their manufacturing facilities meet stringent regulatory standards, including compliance with FDA and EMA guidelines.

Market Presence: Novartis’s global reach ensures that their Cordran products are available across North America, Europe, and select Asian markets, often through authorized distributors.

2. Mylan (Now part of Viatris)

Overview: Mylan has been a significant generic pharmaceutical manufacturer, producing corticosteroid topicals similar to Cordran to meet the demand for affordable dermatological treatments.

Supply Chain Role: Mylan’s manufacturing facilities are strategically located in North America, Europe, and Asia, enabling extensive distribution networks. Their generic flurandrenolide formulations often serve as alternatives or substitutes for brand-name Cordran.

Regulatory Status: Mylan’s products are FDA-approved, with rigorous quality control processes compliant with Good Manufacturing Practices (GMP).

3. Sun Pharmaceutical Industries Ltd.

Overview: As one of India’s largest pharmaceutical companies, Sun Pharma produces a range of topical corticosteroid formulations, including flurandrenolide-based products.

Supply Chain Role: Sun Pharma supplies generic corticosteroid creams and tapes to emerging markets and through export channels to other regions, effectively increasing the availability of Cordran equivalents.

Regulatory Compliance: Their manufacturing complies with global standards like GMP and local regulatory requirements, ensuring product quality.

4. Sandoz (Novartis division)

Overview: Sandoz, a division specializing in generics and biosimilars, supplies corticosteroid topical products, including flurandrenolide formulations, to various markets.

Supply Chain Role: Their extensive manufacturing footprint and global distribution channels facilitate accessibility to generic Cordran products.

---

Additional Notable Suppliers and Considerations

• Teva Pharmaceutical Industries: Known for producing an extensive portfolio of generics, including corticosteroids, Teva supplies products similar to Cordran, often serving North American markets.

• Lupin Limited: An Indian pharmaceutical major manufacturing topical corticosteroids, which may include flurandrenolide formulations.

• Local and Regional Manufacturers: Several regional companies in Latin America, Southeast Asia, and Africa produce corticosteroid topicals, often under local regulatory approvals, diversifying supply sources.

---

Regulatory and Quality Assurance Aspects

Ensuring consistent quality remains crucial among suppliers. Regulatory authorities like the FDA, EMA, and individual country agencies enforce strict GMP standards. Suppliers listed above typically hold the necessary approvals and certifications. Besides, patent statuses influence which manufacturers produce generic versions — once patents expire, a broader array of suppliers enter the market.

Brand vs. Generic Versions: Original brand manufacturers maintain high regulatory and quality standards but often at a higher price point. Generic manufacturers increase market competitiveness, provided they meet regulatory approvals, thus offering more affordable options.

---

Supply Chain Challenges and Market Dynamics

1. Patent Expiry and Generic Competition: Once product patents expire, numerous generic manufacturers gain entry, expanding supplier options but also inducing price competition.
2. Manufacturing Congestion and Quality Concerns: Certain suppliers may face manufacturing bottlenecks due to capacity constraints or quality issues, impacting supply stability.
3. Regional Regulatory Barriers: Different countries have varying approval timelines and standards, affecting supplier accessibility and product availability.
4. Market Consolidation: M&A activities, such as Viatris (Mylan + Pfizer’s generics business), influence the competitive landscape, shaping supplier options.

---

Conclusion

The supply landscape for Cordran involves a combination of original manufacturers—like Novartis—and numerous generic producers, including Mylan, Sun Pharma, and Sandoz. Their ability to adhere to rigorous regulatory standards and maintain robust manufacturing capabilities ensures consistent availability. Stakeholders should monitor patent statuses, regulatory approvals, and regional market conditions that influence supply chain reliability.

---

Key Takeaways

• A diverse set of suppliers, including Novartis, Mylan (Viatris), Sun Pharma, and Sandoz, currently provide Cordran or equivalent flurandrenolide formulations globally.
• Patent expirations have expanded generic production, increasing market competition and affordability.
• Quality assurance and regulatory compliance remain critical selection factors for reliable suppliers.
• Market dynamics—such as mergers, regional regulations, and manufacturing capacity—continuously shape the supply landscape.
• Stakeholders should maintain real-time updates on supplier approvals and manufacturing status to mitigate supply disruptions.

---

Frequently Asked Questions (FAQs)

1. Who are the leading manufacturers of generic Cordran equivalents?
Mylan (now part of Viatris), Sun Pharma, Sandoz, and Teva are among the prominent generic manufacturers producing flurandrenolide-based corticosteroid topicals similar to Cordran.

2. Is Cordran available globally, and are there regional differences in suppliers?
Yes. Availability varies by region. In North America and Europe, original brands are predominant, while in emerging markets, regional generics from companies like Sun Pharma and Lupin dominate.

3. What factors should be considered when selecting a Cordran supplier?
Regulatory approval status, manufacturing quality standards (GMP compliance), product consistency, regional availability, and supply reliability are key considerations.

4. Are there recent patent expirations affecting supplier diversity?
While specific patent timelines for Cordran vary by country, many formulations have faced patent expiration over the past decade, leading to increased generic competition.

5. How do quality standards impact the choice of Cordran suppliers?
Suppliers adhering to GMP and obtaining approvals from agencies like the FDA and EMA ensure product safety, efficacy, and consistency, which are essential for clinical trust and regulatory compliance.

---

References

1. U.S. Food and Drug Administration. Approved Drug Products. [Link to FDA database]
2. European Medicines Agency. Summary of Product Characteristics for corticosteroid topicals. [Link to EMA site]
3. Market intelligence reports on dermatological pharmaceuticals (2022–2023).
4. Company annual reports and regulatory filings.
5. Patent databases and pharmaceutical market analyses.

Note: This article synthesizes publicly available information and industry insights to assist stakeholders in understanding the supplier landscape for Cordran.